JNMT
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arroyo, A. J.
Right arrow Articles by Patel, Y. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arroyo, A. J.
Right arrow Articles by Patel, Y. P.
Journal of Nuclear Medicine Technology Volume 31, Number 1, 2003 18-20
© 2003 by Society of Nuclear Medicine

IMAGING

Factors Affecting the Hepatobiliary Excretion of 99mTc-MAG3: Its Clinical Significance in Routine Renography

Alberto J. Arroyo, BA, FSNMTS, NCT, CNMT;1, Hassan B. Semaan, MD;2, Kirk D. Minkus, MD;2 and Yogesh P. Patel, MD1

1Department of Nuclear Medicine, Division of Radiology, St. Vincent Mercy Medical Center, Toledo, Ohio;
2Department of Radiology, Medical College of Ohio, Toledo, Ohio

Objective:Since the approval of mercaptoacetyltriglycine (MAG3) for routine clinical use, reports have appeared about hepatobiliary excretion deleteriously affecting available diagnostic and quantitative information. The purpose of this study was to evaluate gallbladder (GB) uptake of MAG3 in the clinical setting and its effect on the evaluation of relative renal function and imaging.

Methods:Sixty patients with varying degrees of renal impairment were studied. Routine renal function imaging was followed with anterior and right lateral 3-min abdominal images. Factors such as photolytic degradation, reconstitution steps, 99mTc O4 solution, age, and concentration are discussed. In addition, patient fasting state and radiochemical purity are evaluated. The GB uptake was determined as a percentage of the injected dose.

Results:The MAG3 quality control ranged from 90.9% to 99.0%. The GB uptake ranged from 0.0% (not visualized) to 0.71%. The effective renal plasma flow ranged from 88 to 743 mL/min. There was no correlation between the QC and the percentage of GB uptake (r = 0.12). The majority of patients in the nonfasting state showed minimal or reduced GB uptake when compared with the majority of patients in the fasting state.

Conclusion:Our data suggest that GB uptake of MAG3 is minimal, with no adverse effects on the diagnostic and quantitative analysis of renal function.

Key Words: hepatobiliary; 99mTc-MAG3; excretion






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
THE JOURNAL OF NUCLEAR MEDICINE JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY
Copyright © 2003 by the Society of Nuclear Medicine Technologist Section.